Meta-Flux

BioCorteX

This digital medicine company develops a simulation platform to model drug-microbiome interactions for pharmaceutical and biotechnology clients to improve treatment outcomes.

MetaSight

MetaSight Diagnostics develops multi-omics liquid biopsy tests for the early detection of chronic and acute diseases for healthcare providers and patients.

Applied BioMath

The company develops biosimulation software and mathematical modeling platforms to support drug discovery and development for biotechnology and pharmaceutical organisations.

Metabogen

This company develops microbiome-based probiotics and pharmaceuticals for the probiotic and pharmaceutical industries to treat various health conditions.

PolyModels Hub

This company develops a digital platform for biopharma process development to help scientists design, simulate and optimise pharmaceutical manufacturing workflows.

Metabolys

This biopharmaceutical company develops oral small molecules to treat metabolic diseases, specifically non-alcoholic steatohepatitis and type 2 diabetes, for the global healthcare market.

Revalia

This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.

Multiomic Health

This company develops an artificial intelligence platform for discovering precision medicines and biomarkers for patients with metabolic syndrome-related chronic diseases.